ORM-5029

Product Specifications

Target

Antibody-Drug Conjugates (ADCs)

Related Pathways

Antibody-drug Conjugate/ADC Related

Bioactivity

ORM-5029 is the first antibody-drug conjugate (ADC) targeting the human epidermal growth factor receptor 2 (HER2), combining the highly potent GSPT1 degrader SMol006 with Pertuzumab. It is applicable in cancer research.

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

A22417-10mM-D 10 mM x 1mL in DMSO

Emamectin Benzoate 10mM * 1mL in DMSO

Ask

View Details

397211 1 mg

A-Pinaca

Ask

View Details

MBS8298589-01 5 nmol

hsa-miR-143-5p miRNA Mimic

Ask

View Details

MBS8298589-02 10 nmol

hsa-miR-143-5p miRNA Mimic

Ask

View Details

MBS8298589-03 5x 10 nmol

hsa-miR-143-5p miRNA Mimic

Ask

View Details

T8488-18B 100 mg

[3- (Trimethylammonium) propyl] Methanethiosulfonate Bromide (MTSPT)

Ask

View Details